Novo Nordisk CEO expresses openness to upgrading New York stock listing
Novo Nordisk's CEO has indicated the company's openness to upgrading its New York stock listing. This potential move is aimed at enhancing the pharmaceutical company's profile in the United States, according to an interview the CEO gave to the Financial Times. The company itself is the sole source for this claim.
2 articles from 1 outlet covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
1 outlet covered “Novo Nordisk CEO expresses openness to upgrading New York stock listing”. All of them report the following:
- Novo Nordisk is open to upgrading its New York listing
- The CEO of Novo Nordisk stated this to the Financial Times
- The purpose is to boost the company's U.S. profile
Which outlets covered this?
All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.